Hou J - Search Results

1

Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection.

Yuen MF, Lim SG, Plesniak R, Tsuji K, Janssen HLA, Pojoga C, Gadano A, Popescu CP, Stepanova T, Asselah T, Diaconescu G, Yim HJ, Heo J, Janczewska E, Wong A, Idriz N, Imamura M, Rizzardini G, Takaguchi K, Andreone P, Arbune M, Hou J, Park SJ, Vata A, Cremer J, Elston R, Lukić T, Quinn G, Maynard L, Kendrick S, Plein H, Campbell F, Paff M, Theodore D; B-Clear Study Group. Yuen MF, et al. Among authors: hou j. N Engl J Med. 2022 Nov 24;387(21):1957-1968. doi: 10.1056/NEJMoa2210027. Epub 2022 Nov 8. N Engl J Med. 2022. PMID: 36346079 Clinical Trial.

2

[Selective transmission of hepatitis B virus variant with S gene mutation between HBV-carrier mothers and their infants].

Zhang J, Wang ZH, Hou JL, Yang H, Cheng AL, Li XH. Zhang J, et al. Among authors: hou jl. Di Yi Jun Yi Da Xue Xue Bao. 2002 Sep;22(9):806-7, 810. Di Yi Jun Yi Da Xue Xue Bao. 2002. PMID: 12297437 Chinese.

3

[Dynamic changes of basal core promoter and pre-core mutants of hepatitis B virus in patients with chronic hepatitis B virus infection].

Chen J, Hou J, Wang Z. Chen J, et al. Among authors: hou j. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 1999 Mar;13(1):57-60. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 1999. PMID: 12759956 Chinese.

4

Clinical and histological characteristics of chronic hepatitis B with negative hepatitis B e-antigen.

Peng J, Luo K, Zhu Y, Guo Y, Zhang L, Hou J. Peng J, et al. Among authors: hou j. Chin Med J (Engl). 2003 Sep;116(9):1312-7. Chin Med J (Engl). 2003. PMID: 14527355

5

[Clinical significance of neutralizing anti-interferon antibodies in chronic hepatitis B patients treated with recombinant interferon-alpha].

Mao QG, Luo KX, Liu DL, Zhang MX, Hou JL. Mao QG, et al. Zhonghua Gan Zang Bing Za Zhi. 2004 Apr;12(4):205-7. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15099466 Chinese.

6

Clinical and virological characteristics of lamivudine resistance in chronic hepatitis B patients: a single center experience.

Sun J, Wang Z, Ma S, Zeng G, Zhou Z, Luo K, Hou J. Sun J, et al. Among authors: hou j. J Med Virol. 2005 Mar;75(3):391-8. doi: 10.1002/jmv.20281. J Med Virol. 2005. PMID: 15648063

7

[A study of the causes of poor antiviral responses in male chronic hepatitis B patients treated with recombinant interferon-alpha].

Mao QG, Liu DL, Zhang MX, Feng XR, Hou JL. Mao QG, et al. Zhonghua Gan Zang Bing Za Zhi. 2005 Jan;13(1):24-6. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 15670486 Chinese.

8

[Influences of the genotypes of HBV and HBeAg regarding their response to PEG-IFN in chronic hepatitis B patients].

Fan HB, Guo YB, Luo KX, Hou JL, Wang ZH, Zhang MX. Fan HB, et al. Zhonghua Gan Zang Bing Za Zhi. 2005 Jul;13(7):488-90. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 16042879 Chinese.

9

Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China.

Zhao H, Kurbanov F, Wan MB, Yin YK, Niu JQ, Hou JL, Wei L, Wang GQ, Tanaka Y, Mizokami M, Si CW. Zhao H, et al. Clin Infect Dis. 2007 Feb 15;44(4):541-8. doi: 10.1086/511042. Epub 2007 Jan 11. Clin Infect Dis. 2007. PMID: 17243057 Clinical Trial.

10

Clinical and virological characteristics of hepatitis B virus subgenotypes Ba, C1, and C2 in China.

Wang Z, Tanaka Y, Huang Y, Kurbanov F, Chen J, Zeng G, Zhou B, Mizokami M, Hou J. Wang Z, et al. Among authors: hou j. J Clin Microbiol. 2007 May;45(5):1491-6. doi: 10.1128/JCM.02157-06. Epub 2007 Mar 21. J Clin Microbiol. 2007. PMID: 17376881 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,254 results

Search Page